Skip to main content

Bokhary Foods, Inc. Recall: Products contain undeclared sulfites.

United States

TerminatedClass I

Company
Bokhary Foods, Inc.
Product
GODAVARI brand APRICOTS, packaged in 7 oz (UPC 0 03658 50001…
Recall date
December 10, 2021
Terminated
December 8, 2023
Source
FDA

Reason for recall

Products contain undeclared sulfites.

  1. - Recall initiated
  2. - Reported by source
  3. - Recall terminated
Recalled products
Product description UPC Quantity Lot / code information
GODAVARI brand APRICOTS, packaged in 7 oz (UPC 0 03658 50001 4) and 14 oz (UPC 0 03657 5001 5) clear plastic-film bags with the GODAVARI brand label on the front. Each bag is filled with orange-colored dried apricots that can be seen through the bag. Not published in this source record 3-28lb boxes 7-oz product 14-oz product There is no other coding on the packaging.

Distribution

  • MA
  • CT
  • NY

Official source record

Agency
FDA
Dataset
FDA Food Enforcement (Recalls)
Recall number
F-0362-2022
Event ID
89207
Status
Terminated
Classification
Class I
Company
Bokhary Foods, Inc.
Product description
GODAVARI brand APRICOTS, packaged in 7 oz (UPC 0 03658 50001 4) and 14 oz (UPC 0 03657 5001 5) clear plastic-film bags with the GODAVARI brand label on the front. Each bag is filled with orange-colored dried apricots that can be seen through the bag.
Quantity
3-28lb boxes
Reason
Products contain undeclared sulfites.
Recall initiation date
December 10, 2021
Report date
January 12, 2022
Classification date
Not published in this source record
Termination date
December 8, 2023
Distribution pattern
MA, CT, NY
UPC, lot, and code information
7-oz product 14-oz product There is no other coding on the packaging.
Voluntary or mandated
Voluntary: Firm initiated
Initial notification method
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Source last updated
Not tracked separately from the Public Health Trace retrieval date below
Public Health Trace retrieval date

Responsible company: Bokhary Foods, Inc.

Distribution map

A map highlighting the states named in the source's distribution description.

Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.

Distribution map
State Distributed
Massachusetts 1
Connecticut 1
New York 1

States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class I mean?

A situation in which there is a reasonable probability that use of or exposure to a product will cause serious adverse health consequences or death.

Is this recall still active?

According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.